Adamed Pharma S.A. Oncotec Pharma Produktion GmbH Tecnimede - Sociedade Tecnico-Medicinal S.A.

Poland

All drugs from this manufacturer

  • ADABONIB

    The medicine is used to treat multiple myeloma (a type of bone marrow cancer) and mantle cell lymphoma (a type of cancer that affects the lymph nodes) in adults.

    Dosage form: powder for preparation of injection solution

    Active substance Dosage
    bortezomib 3.5 mg

    ATC: L01XG01